Aristopharma Ltd

News

 

Aristopharma introduces AROMATIN tablet for the women with breast cancer

Breast cancer is the most common cancer in women in Bangladesh. For the postmenopausal women with breast cancer, Aristopharma has recently introduced Aromatin film coated tablet. It is a preparation of Anastrozole USP 1 mg. Even after breast cancer surgery, the biosynthesis of estrogen (Aromatization) has to be stopped to prevent the recurrence of estrogen receptor positive (ER+) breast cancer in postmenopausal women. Anastrozole is highly effective and safe non-steroidal aromatase inhibitor which can stop the conversion of androgen into estrogen (the process called aromatization). Hence, it can strongly prevent the recurrence of breast cancer. Anastrozole can be used as adjuvant, first line and second line treatment option for breast cancer. It is safe for renal and hepatic impaired patients. The dose is- 1 tablet per day and the price is affordable.